NCT06371222View on ClinicalTrials.gov

Role of Ivabradine on Heart Rate and Quality of Life in Patients With Mitral Stenosis in Sinus Rhythm

PHASE4CompletedINTERVENTIONAL

Enrollment

42

Participants

Timeline

Start Date

February 1, 2023

Primary Completion Date

January 31, 2024

Study Completion Date

February 1, 2024

Conditions

Mitral Stenosis

Interventions

DRUG

Ivabradine

5 mg for 3 months

DRUG

Beta blocker

controlled group

Trial Locations (1)

1200

BSMMU, Dhaka

All Listed Sponsors

lead

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

OTHER